लोड हो रहा है...

Effects of 6-month eicosapentaenoic acid treatment on postprandial hyperglycemia, hyperlipidemia, insulin secretion ability, and concomitant endothelial dysfunction among newly-diagnosed impaired glucose metabolism patients with coronary artery disease. An open label, single blinded, prospective randomized controlled trial

BACKGROUND: Recent experimental studies have revealed that n-3 fatty acids, such as eicosapentaenoic acid (EPA) regulate postprandial insulin secretion, and correct postprandial glucose and lipid abnormalities. However, the effects of 6-month EPA treatment on postprandial hyperglycemia and hyperlipi...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Cardiovasc Diabetol
मुख्य लेखकों: Sawada, Takahiro, Tsubata, Hideo, Hashimoto, Naoko, Takabe, Michinori, Miyata, Taishi, Aoki, Kosuke, Yamashita, Soichiro, Oishi, Shogo, Osue, Tsuyoshi, Yokoi, Kiminobu, Tsukishiro, Yasue, Onishi, Tetsuari, Shimane, Akira, Taniguchi, Yasuyo, Yasaka, Yoshinori, Ohara, Takeshi, Kawai, Hiroya, Yokoyama, Mitsuhiro
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: BioMed Central 2016
विषय:
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC5002116/
https://ncbi.nlm.nih.gov/pubmed/27565734
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12933-016-0437-y
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!